Neuronetics, Inc. is a privately held medical device company focused on developing non-invasive therapies for psychiatric and neurological disorders using MRI-strength magnetic field pulses. They are the first and only company to have a non-systemic and non-invasive depression treatment cleared by the FDA for patients who have not benefited from prior antidepressant treatment. Based in Malvern, PA, they are the leader in the development of TMS Therapy (transcranial magnetic stimulation), a non-invasive form of neuromodulation.
Funding Rounds (8) - $161.3MUpdate
|Date||Amount / Round||Valuation||Lead Investor||Investors|
|Apr, 2015||$34.3M / Series F||—||GE Ventures||9|
|May, 2011||$30M / Series E||—||8|
|Oct, 2009||$30M / Series D||—||New Leaf Venture Partners||8|
|Aug, 2006||$35M / Series C||—||—||6|
|Nov, 2005||$8.5M / Series B||—||—||5|
|Mar, 2005||$8.5M / Series B||—||—||5|
|Aug, 2003||undisclosed amount / Seed||—||—||2|
|Apr, 2003||$15M / Series A||—||—||4|
Current Team (12)Update
31 General Warren Blvd.
Malvern, PA 19355